• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[放射性免疫法测定癌伴骨转移所致高钙血症患者血浆甲状旁腺激素]

[Radioimmunologic determination of plasma parathormone in hypercalcemia caused by cancer with osseous metastases].

作者信息

Lemaire V, Gueris J, Cassou M, Ryckewaert A

出版信息

Rev Rhum Mal Osteoartic. 1977 Dec;44(12):709-13.

PMID:609875
Abstract

The plasma parathormone was measured by radioimmunological determination in 23 cases of cancer with bone metastases, 8 of mammary origin. In 11 cases the plasma parathormone (iPTH) was less than 4 ng/ml (lower normal limit), as might be expected in view of the hypercalcemia. In 12 cases the iPTH was higher than 4 ng/ml, in 8 of these higher than 8 ng/ml (upper normal limit). These results are suggestive of the role of a substance analogous to parathormone in the genesis of the hypercalcaemia and peritumoral bone resorption of bone metastases of solid tumors.

摘要

采用放射免疫法对23例伴有骨转移的癌症患者进行血浆甲状旁腺激素检测,其中8例为乳腺癌骨转移。鉴于存在高钙血症,11例患者的血浆甲状旁腺激素(iPTH)低于4 ng/ml(正常下限)。12例患者的iPTH高于4 ng/ml,其中8例高于8 ng/ml(正常上限)。这些结果提示,在实体瘤骨转移的高钙血症及肿瘤周围骨吸收的发生过程中,一种类似于甲状旁腺激素的物质发挥了作用。

相似文献

1
[Radioimmunologic determination of plasma parathormone in hypercalcemia caused by cancer with osseous metastases].[放射性免疫法测定癌伴骨转移所致高钙血症患者血浆甲状旁腺激素]
Rev Rhum Mal Osteoartic. 1977 Dec;44(12):709-13.
2
[Radioimmunologic determination of plasma parathyroid hormone in hypercalcemia caused by cancer with osseous metastasis].[骨转移癌所致高钙血症中血浆甲状旁腺激素的放射免疫测定]
Nouv Presse Med. 1977 Oct 22;6(35):3236.
3
Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia.甲状旁腺激素相关肽在高钙血症评估中的作用。
Rev Rhum Engl Ed. 1995 Mar;62(3):189-96.
4
[Malignant hypercalcemia after treatment of breast cancer].
J Gynecol Obstet Biol Reprod (Paris). 1992;21(7):775-7.
5
Parathyroid hormone-related protein, bone metastases and hypercalcaemia of malignancy.甲状旁腺激素相关蛋白、骨转移和恶性肿瘤高钙血症
Ann R Coll Surg Engl. 1996 Jul;78(4):354-8.
6
Stimulation of calcium reabsorption observed in advanced breast cancer patients with hypercalcemia and multiple bone metastases.在患有高钙血症和多处骨转移的晚期乳腺癌患者中观察到钙重吸收的刺激作用。
Jpn J Cancer Res. 1985 Apr;76(4):308-14.
7
[Determination of plasma parathyroid hormone in the differential diagnosis of hypercalcemias associated with malignant tumors].[血浆甲状旁腺激素测定在伴恶性肿瘤高钙血症鉴别诊断中的应用]
Schweiz Med Wochenschr. 1978 Jul 8;108(27):1031-4.
8
[Performances of two kits for parathyroid hormone-related peptide (PTHrP) assay in the additional study of malignant hypercalcemias].[两种甲状旁腺激素相关肽(PTHrP)检测试剂盒在恶性高钙血症附加研究中的性能]
Pathol Biol (Paris). 1995 Nov;43(9):799-805.
9
Plasma prostaglandin E in patients with cancer with and without hypercalcemia.患有和未患有高钙血症的癌症患者的血浆前列腺素E
J Clin Endocrinol Metab. 1976 Dec;43(6):1330-5. doi: 10.1210/jcem-43-6-1330.
10
[Contributions of radioimmunoassay of plasma parathormone in human disease].[血浆甲状旁腺激素放射免疫测定在人类疾病中的作用]
Nouv Presse Med. 1974 Jun 22;3(25):1607-11.